John David

Q: What Schools Are Affiliated With John David

John David is affiliated with the following schools: Tufts University, Stanford University, University of Chicago, Johns Hopkins University, Massachusetts General Hospital, Harvard University

John David 's AcademicInfluence.com Rankings

John David

Philosophy

#3842

World Rank

#6138

Historical Rank

Logic

#1449

World Rank

#2204

Historical Rank

philosophy Degrees

Download Badge

Philosophy

John David 's Degrees

Doctorate Medicine Harvard University

Why Is John David Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John David is an American physician that is currently the Richard Pearson Strong Professor of Tropical Public Health, Emeritus at Harvard School of Public Health. David earned his medical degree at the University of Chicago.

(See a Problem?)

John David 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. (1966) (1215)
Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis (1999) (580)
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response (2001) (573)
DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS. (1964) (536)
ALTERATIONS OF MACROPHAGE FUNCTIONS BY MEDIATORS FROM LYMPHOCYTES (1971) (488)
In vitro methods in cell mediated and tumor immunity (1976) (356)
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. (1979) (348)
Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. (1989) (334)
A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. (1979) (322)
rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. (1996) (309)
Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. (1986) (283)
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. (1976) (263)
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. (1978) (255)
An in vitro assay for cellular hypersensitivity in man. (1970) (252)
Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. (1972) (241)
Leukotactic Factor Produced by Sensitized Lymphocytes (1969) (223)
CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONS (1973) (221)
STUDIES ON MEDIATOR PRODUCTION BY HIGHLY PURIFIED HUMAN T AND B LYMPHOCYTES (1974) (220)
Sandfly Maxadilan Exacerbates Infection with Leishmania major and Vaccinating Against It Protects Against L. major Infection1 (2001) (215)
DELAYED HYPERSENSITIVITY IN VITRO. II. EFFECT OF SENSITIVE CELLS ON NORMAL CELLS IN THE PRESENCE OF ANTIGEN. (1964) (214)
Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. (1998) (206)
Passive transfer by cells of type II collagen-induced arthritis in rats. (1978) (205)
THE ENHANCEMENT OF MACROPHAGE BACTERIOSTASIS BY PRODUCTS OF ACTIVATED LYMPHOCYTES (1973) (203)
Monoclonal antibodies that distinguish between New World species of Leishmania (1981) (196)
The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. (1970) (188)
Cellular sensitivity to collagen in rheumatoid arthritis. (1978) (186)
Macrophage Migration Inhibitory Factor Deficiency Impairs Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice (2004) (174)
Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages (1987) (174)
Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies. (1987) (172)
Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. (1986) (170)
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils (1977) (161)
Results of a World Health Organization-sponsored workshop to characterize antigens recognized by mycobacterium-specific monoclonal antibodies (1986) (161)
Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. (1981) (160)
Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. (2005) (148)
Stress-induced enhancement of skin immune function: A role for γ interferon (2000) (146)
Schistosoma mansoni. Anti-egg monoclonal antibodies protect against cercarial challenge in vivo (1984) (144)
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. (1971) (143)
The regulation of human eosinophil function by cytokines. (1987) (142)
Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection (2001) (139)
Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. (1975) (138)
Asymptomatic human carriers of Leishmania chagasi. (2002) (138)
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia (2006) (132)
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. (1980) (132)
Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll. (1982) (132)
Development of chronic colitis is dependent on the cytokine MIF (2001) (131)
The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. (1998) (128)
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. (1970) (125)
Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. (1970) (122)
Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. (1972) (118)
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. (2003) (118)
CALCITONIN GENE-RELATED PEPTIDE INHIBITS LOCAL ACUTE INFLAMMATION AND PROTECTS MICE AGAINST LETHAL ENDOTOXEMIA (2005) (117)
Lymphocyte mediators and cellular hypersensitivity. (1973) (117)
Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium (2002) (116)
Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil (2006) (115)
Monoclonal antibodies that distinguish subspecies of Leishmania braziliensis. (1982) (115)
Cutaneous leishmaniasis in Ceara state in northeastern Brazil: incrimination of Lutzomyia whitmani (Diptera: Psychodidae) as a vector of Leishmania braziliensis in baturite municipality. (1994) (114)
Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. (1981) (113)
Prevention of MIF activity by agents known to increase cellular cyclic AMP. (1973) (111)
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis (2013) (110)
Immune evasion by Schistosoma mansoni: loss of susceptibility to antibody or complement-dependent eosinophil attack by schistosomula cultured in medium free of macromolecules (1981) (103)
Macrophage migration. (1968) (101)
SUPPRESSION OF DELAYED HYPERSENSITIVITY IN VITRO BY INHIBITION OF PROTEIN SYNTHESIS (1965) (101)
Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. (1998) (101)
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. (1970) (100)
Competence of the human host as a reservoir for Leishmania chagasi. (2000) (99)
Autoimmunity to collagen in adjuvant arthritis of rats. (1980) (97)
Macrophage activation by lymphocyte mediators. (1975) (95)
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. (1972) (92)
Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous Leishmania major Infection1 (2000) (91)
Enhanced Th2‐like responses in IL‐1 type 1 receptor‐deficient mice (1998) (89)
Effect of psychological stress on the induction of arthritis in rats. (1980) (88)
IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to Trichinella spiralis infection (1981) (88)
Inhibition of leukocyte migration: an evaluation of this in vitro assay of delayed hypersensitivity in man to a soluble antigen. (1970) (86)
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: mediation by IgG, and inhibition by antigen-antibody complexes. (1977) (86)
Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. (2004) (86)
The Urban Spread of Visceral Leishmaniasis: Clues from Spatial Analysis (2002) (84)
METABOLIC AND FUNCTIONAL STUDIES ON ACTIVATED MOUSE MACROPHAGES (1973) (84)
Eosinophil function. (1981) (81)
Protective Effect on Leishmania major Infection of Migration Inhibitory Factor, TNF-α, and IFN-γ Administered Orally via Attenuated Salmonella typhimurium (1998) (80)
Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A. (1972) (79)
Cutting Edge: Susceptibility to the Larval Stage of the Helminth Parasite Taenia crassiceps Is Mediated by Th2 Response Induced Via STAT6 Signaling1 (2002) (79)
Cellular Hypersensitivity and Immunity (Part 1 of 3) (1972) (79)
STAT‐4 mediated IL‐12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis (1999) (78)
Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. (1976) (78)
Effect of Multiparity on Human Maternal Hypersensitivity to Foetal Antigen (1973) (75)
IL‐12 gene‐deficient C57BL / 6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology (2000) (75)
Macrophage Migration Inhibitory Factor Plays a Critical Role in Mediating Protection against the Helminth Parasite Taenia crassiceps (2003) (75)
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis (2006) (74)
Autoimmunity to Collagen (1981) (71)
IMMUNOCHEMICAL STUDIES ON THE SPECIFICITY OF CELLULAR HYPERSENSITIVITY (1968) (71)
Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. (1995) (70)
The adherence of human neutrophils and eosinophils to schistosomula: evidence for membrane fusion between cells and parasites (1980) (69)
DELAYED HYPERSENSITIVITY IN VITRO. 3. THE SPECIFICITY OF HAPTEN-PROTEIN CONJUGATES IN THE INHIBITION OF CELL MIGRATION. (1964) (68)
THE COMPARTMENTALIZATION OF ANTIGEN-REACTIVE LYMPHOCYTES IN DESENSITIZED GUINEA PIGS (1971) (68)
Natural infection of Lutzomyia (Nyssomyia) whitmani (Antunes & Coutinho, 1939) by Leishmania of the braziliensis complex in Baturité, Ceará State, northeast Brazil. (1990) (66)
Association of hepatosplenic schistosomiasis with HLA-DQB1*0201. (1996) (66)
Cloning of a developmentally regulated tegument antigen of Schistosoma mansoni. (1986) (64)
IN VITRO DEMONSTRATION OF CELLULAR SENSITIVITY IN ALLERGIC ENCEPHALOMYELITIS (1965) (64)
Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s) (1982) (64)
Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. (1999) (63)
Macrophage Activation by Lymphocyte Mediators and Studies on the Interaction of Macrophage Inhibitory Factor (MIF) with Its Target Cell (1976) (63)
Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. (1993) (61)
Activation of human blood monocytes by products of sensitized lymphocytes. (1974) (60)
Further studies on migration inhibitory factor (MIF): evidence for its glycoprotein nature. (1971) (60)
Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis. (1993) (59)
In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages. (1981) (59)
Activation of eosinophils in cancer patients treated with IL-2 and IL-2-generated lymphokine-activated killer cells. (1989) (58)
Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products. (1979) (56)
Stress-induced enhancement of skin immune function: A role for gamma interferon. (2000) (56)
Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide. (1989) (55)
Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni. (1984) (54)
Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. (1991) (54)
2 – ASSAY FOR INHIBITION OF MACROPHAGE MIGRATION (1971) (52)
Studies on human migration inhibitory factor: characterization of three molecular species. (1981) (51)
THE IN VITRO DESENSITIZATION OF SENSITIVE CELLS BY TRYPSIN (1964) (51)
Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites. (1985) (51)
Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF). (1978) (50)
Cellular Hypersensitivity and Immunity (1972) (50)
The PACAP‐type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL‐10 (1998) (50)
Partial characterization of murine migration inhibitory factor (MIF). (1976) (49)
Schistosomula of Schistosoma mansoni clear concanavalin A from their surface by sloughing (1982) (49)
Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. (1975) (49)
Structural characterization and chromosomal location of the mouse macrophage migration inhibitory factor gene and pseudogenes. (1995) (47)
Identification by monoclonal antibody of a major (28 kDa) surface membrane antigen of Schistosoma mansoni. (1985) (47)
In vivo protection against Leishmania mexicana mediated by monoclonal antibodies. (1983) (47)
In vitro lymphocyte response of patients with immunologic deficiency diseases. (1970) (47)
Differential mRNA responses in human macrophages activated by interferon-gamma and muramyl dipeptide. (1987) (45)
Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes. (1975) (45)
In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis (1987) (44)
In vitro Studies on Homograft Sensitivity (1965) (43)
Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187. (1986) (43)
Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. (1980) (42)
American cutaneous leishmaniasis: in situ characterization of the cellular immune response with time. (1994) (41)
Leishmaniasis in Brazil: XXIII. The identification of Leishmania braziliensis braziliensis in wild-caught neotropical sandflies using monoclonal antibodies. (1987) (41)
Mediators produced by sensitized lymphocytes. (1971) (41)
Expression of strain‐specific surface antigens on Plasmodium falciparum‐infected erythrocytes (1982) (40)
Detection in vitro of cellular hypersensitivity to drugs. (1971) (40)
Mechanism of the interaction mediating killing of Schistosoma mansoni by human eosinophils. (1980) (39)
An in vitro model for infection with Leishmania major that mimics the immune response in mice (1997) (39)
NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response. (1999) (39)
The identity of Leishmania isolated from sand flies and vertebrate hosts in a major focus of cutaneous leishmaniasis in Baturite, northeastern Brazil. (1994) (38)
Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. (2006) (38)
Partial and complete detachment of neutrophils and eosinophils from schistosomula: evidence for the establishment of continuity between a fused and normal parasite membrane (1980) (38)
A cloned ATP:guanidino kinase in the trematode Schistosoma mansoni has a novel duplicated structure. (1990) (37)
Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism. (1981) (37)
The Activation of Macrophages by Lymphokines (1979) (35)
Biology of Leishmania and Leishmaniasis (1988) (35)
Cutting Edge: Deficiency of Macrophage Migration Inhibitory Factor Impairs Murine Airway Allergic Responses1 (2006) (35)
Effect of isoproterernol and aminiphylline on cyclic AMP levels of guinea pig macrophages. (1976) (35)
Juvenile rheumatoid arthritis. Cellular hypersensitivity and selective IgA deficiency. (1972) (34)
Schistosoma mansoni: post-transformational surface changes in schistosomula grown in vitro and in mice. (1980) (34)
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. I. Stable and irreversible antibody-dependent adherence. (1980) (33)
Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. (1977) (33)
Alteration of some functional and metabolic characteristics of resident mouse peritoneal macrophages by lymphocyte mediators (1978) (33)
Structure and arrangement of the beta-tubulin genes of Leishmania tropica (1984) (33)
Isolation of a guinea pig macrophage glycolipid with the properties of the putative migration inhibitory factor receptor. (1982) (32)
Role of sialic acid in the macrophage glycolipid receptor for MIF. (1980) (32)
Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole. (1975) (31)
Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. (1998) (31)
Lymphocytic Factors in Cellular Hypersensitivity (1971) (30)
Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae. (1987) (30)
Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. (1981) (30)
Altered T helper responses in CD40 and interleukin-12 deficient mice reveal a critical role for Th1 responses in eliminating the helminth parasite Taenia crassiceps. (2003) (29)
βδ T Cells Are Not Essential for Control of Cutaneous Leishmania major Infection in Genetically Resistant C57BL/6 Mice (1997) (29)
Cell-mediated cytotoxicity to Trypanosoma cruzi. II. Antibody-dependent killing of bloodstream forms by mouse eosinophils and neutrophils. (1981) (28)
Ly phenotype of lymphocytes producing murine migration inhibitory factor (MIF). (1980) (27)
Guinea pig lymphotoxin (LT). II. Physicochemical properties of LT produced by lymphocytes stimulated with antigen or concanavalin A: its differentiation from migration-inhibitory factor (MIF). (1973) (27)
Levamisole and cell-mediated immunity. (1973) (27)
Glycolipid affinity purification of migration inhibitory factor (1982) (26)
Pernicous anaemia, hypogammaglobulinaemia, and altered lymphocyte reactivity. A family study. (1972) (26)
Leishmania (Viannia) braziliensis: comparative pathology of golden hamsters infected with isolates from cutaneous and mucosal lesions of patients residing in Tres Bracos, Bahia, Brazil. (1991) (26)
A macrophage surface component related to fibronectin is involved in the response to migration inhibitory factor. (1981) (26)
Guinea pig lymphotoxin (LT). I. In vitro studies of LT produced in response to antigen stimulation of lymphocytes. (1973) (24)
IN VITRO STUDIES OF THE SUPPRESSION OF DELAYED HYPERSENSITIVITY BY THE INDUCTION OF PARTIAL TOLERANCE (1970) (23)
Autoimmunity induced by type II collagen-coupled spleen cells. (1981) (23)
Maturation In Vivo of Schistosoma mansoni Schistosomula After Culture In Vitro with Granulocytes and Antibody (1983) (23)
Transfer factor treatment of chronic mucocutaneous candidiasis: requirement for donor reactivity to candida antigen. (1978) (22)
Migration inhibitory factor (MIF) and proliferative responses by human lymphocyte subpopulations separated by sheep erythrocyte rosette formation. (1976) (22)
Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections. (1980) (21)
Reviews of Infectious Diseases (2016) (21)
Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration. (1972) (21)
Monoclonal antibodies recognizing determinants specific for the promastigote state of Leishmania mexicana. (1982) (21)
Migration Inhibitory Factor and Mediators of Cellular Hypersensitivity in Vitro (1971) (20)
Blockade of Macrophage Migration Inhibitory Factor Does Not Prevent Acute Renal Allograft Rejection (2003) (19)
Eosinophil-mediated killing of schistosomula of Schistosoma mansoni: oxidative requirement for enhancement by eosinophil colony stimulating factor (CSF-alpha) and supernatants with eosinophil cytotoxicity enhancing activity (E-CEA). (1984) (19)
Increased responsiveness to macrophage-activating factor (MAF) after alteration of macrophage membranes. (1977) (19)
In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity. (1973) (18)
Collagens stimulate the production of mononuclear cell factor (MCF) and prostaglandins (PGE2) by human monocytes. (1980) (18)
A cloned DNA fragment for identification of Mycobacterium tuberculosis. (1989) (18)
Partial purification of antigens from eggs of Schistosoma mansoni that elicit delayed hypersensitivity. (1977) (18)
Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole. (1977) (17)
Stimulation of guinea pig macrophage pinocytosis by lipopolysaccharides (LPS): evidence that LPS acts directly on the macrophage. (1980) (17)
Cellular sensitivity to collagen in rheumatoid arthritis. (1978) (17)
Phlebotomine sandfly (Diptera: Psychodidae) fauna survey in an American cutaneous leishmaniasis (ACL) focus in Baturité, Ceará State, northeast Brazil. (1991) (17)
Modulation of the cytotoxicity of human blood eosinophils by factors secreted by monocytes and T lymphocytes. (1983) (16)
Dexamethasone: antirheumatic properties, hormonal effects and adverse reactions (a 16 month study). (1960) (15)
Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon. (1977) (15)
METHOD FOR THE PRODUCTION OF MIF BY HUMAN BLOOD LYMPHOCYTES (1971) (14)
Delayed Hypersensitivity ire vitro. I. The Specificity of Inhibition of Cell Migration by Antigens. II. Effect of Sensitive Cells on Normal Cells in the Presence of Antigen. (1964) (14)
Abrogation of type II collagen-induced arthritis in rats by psychological stress. (1979) (14)
Macrophage glycolipid receptors for human migration inhibitory factor (MIF): differentiated HL-60 cells exhibit MIF responsiveness and express surface glycolipids which both bind MIF and convert nonresponsive cells to responsiveness. (1985) (14)
Further characterization of the putative glycolipid receptor for MIF: role of fucose associated with an acidic glycolipid. (1980) (14)
Plasmodium falciparum: DNA probe diagnosis of malaria in Kenya. (1989) (14)
Generation of human hybridomas producing migration inhibitory factor (MIF) and of murine hybridomas secreting monoclonal antibodies to human MIF. (1985) (13)
Recombinant human migration inhibitory factor has adjuvant activity. (1992) (13)
Enhanced uptake of 3H-glucosamine by macrophages stimulated by macrophage-activating factor. (1979) (13)
Inability to block the activity of guinea pig migration inhibitory factor with di‐isopropyl phosphorofluoridate (1974) (13)
Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole. (1975) (12)
Cellular hypersensitivity in Guillain-Barré syndrome. (1974) (12)
Effect of migration inhibitory factor (MIF) on cyclic AMP levels of guinea pig macrophages. (1976) (12)
Sensitivity and specificity of a recombinant Leishmania chagasi antigen in the serodiagnosis of visceral leishmaniasis. (1993) (12)
An assay for human lymphocyte mitogenic factor: B-lymphocyte stimulation by a T-lymphocyte product. (1978) (11)
Mechanisms of eosinophil mediated helminthotoxicity. (1980) (10)
Cell-associated hypersensitivity studied in vitro. (1968) (10)
The successful use of radiofrequency-induced heat therapy for cutaneous leishmaniasis: a review (2018) (10)
IN VITRO STUDIES ON DELAYED HYPERSENSITIVITY AND HOMOGRAFT IMMUNITY * (1964) (10)
Gammadelta T cells are not essential for control of cutaneous Leishmania major infection in genetically resistant C57BL/6 mice. (1997) (9)
MACROPHAGE ACTIVATION BY LYMPHOCYTE MEDIATORS AND TUMOR IMMUNITY: A BRIEF REVIEW (1976) (9)
The elusive humors of the lymphocyte mediators of delayed hypersensitivity. (1971) (9)
Lymphokines and macrophages. (1983) (8)
Macrophage accumulation and renal fibrosis are independent of macrophage migration inhibitory factor in mouse obstructive nephropathy (2004) (8)
Fractionation of murine macrophage inhibitory factor into two distinct species. (1981) (8)
In vitro enhancement of the helminthotoxic capacity of human blood eosinophils. (1981) (8)
Leishmania (Viannia) braziliensis isolated from cutaneous and mucosal lesions of patients residing in Tres Bracos, Bahia, Brazil differ in virulence for the golden hamster. (1990) (8)
Immunology of parasitic infections: report of a Workshop. National Naval Medical Center Auditorium, Bethesda, Maryland 1-3 June, 1977. (1977) (8)
Lymphocyte-macrophage interaction in resistance to Listeria momocytogenes. (1973) (8)
Stimulation of pinocytosis in the macrophage by lymphocyte mediators. I. Description of the phenomenon. (1980) (7)
Glycolipid-dependent interaction between human migration-inhibitory factor and mononuclear phagocytes. (1984) (7)
Immunity ot Schistosoma mansoni: antibody-dependent eosinophil-mediated damage to schistosomula. (1977) (7)
A serum factor that suppresses the cytotoxic function of cytokine- stimulated human eosinophils (1990) (7)
Dissociation of human interferon-gamma-like activity from migration-inhibition factor. (1984) (6)
Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase. (1979) (6)
Immunity to schistosomes: advances and prospects. (1979) (6)
gd T Cells Are Not Essential for Control of Cutaneous Leishmania major Infection in Genetically Resistant C57BL/6 Mice (1997) (6)
Heat-labile and heat-stable anti-schistosomular antibodies in Kenyan schoolchildren infected with Schistosoma mansoni. (1981) (6)
A method for the detection of antibodies in mice following graft rejection. (1969) (5)
Stimulation of pinocytosis in the macrophage by lymphocyte mediators. II. Evidence that the stimulating factor is MAF, and studies on the cellular requirements for response to the mediator. (1980) (5)
Macrophage migration inhibition test. (1970) (5)
DELAYED HYPERSENSITIVITY IN VITRO ITS MEDIATION BY SOLUBLE SUBSTANCES FORMED DURING THE REACTION OF ANTIGEN WITH SENSITIVE LYMPHOID CELLS (1968) (5)
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia (2015) (5)
Glycolipid receptor for human migration inhibitory factor: fucose and sialic acid are important for the human monocyte response to migration inhibitory factor. (1985) (5)
Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model. (1975) (5)
Mice with STAT 6-Targeted Gene Disruption Develop a Th 1 Response and Control Cutaneous Leishmaniasis 1 (1998) (5)
Cellular sensitivity to tumors. (1970) (4)
Macrophage activation induced by lymphocyte mediators. (1975) (4)
Comparison of the ability of eosinophils and neutrophils, and of eosinophils from patients with S. mansoni infection and normal individuals, to mediate in vitro damage to schistosomula of S. mansoni. (1979) (4)
An attempt to produce immune tolerance to thyroglobulin in rabbits. (1961) (4)
A Monoclonal Antibody Against Migration Inhibitory Factor (MIF) Obtained by Immunization With MIF From the Human Lymphoblast Cell Line Mo (1986) (4)
8 – IN VITRO ASSAY FOR INHIBITION OF MIGRATION OF HUMAN BLOOD LEUCOCYTES (1971) (4)
Summary of round table discussion on methods concerned with leukocyte migration. (1972) (3)
Characterization of migration inhibitory factor (MIF) and its separation from a chemotactic factor for monocytes. (1971) (3)
MIF/MAF-Macrophage Interactions: Biochemical Characterization of a Putative Glycolipid Receptor for MIF and the Existence and Properties of Two Distinct MIFs (1980) (3)
Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes. (1975) (3)
Human mitogenic factor: An example of T-B lymphocyte interaction☆☆☆ (1976) (3)
COMBINATION TRANSFER FACTOR-AMPHOTERICIN B THERAPY IN A CASE OF CHRONIC MUCOCUTANEOUS CANDIDIASIS: A CONTROLLED STUDY (1976) (3)
TRANSFER FACTOR: IN VITRO EFFECTS ON LYMPHOCYTE TRANSFORMATION (1976) (3)
Passive transfer of immunity in human Schistosomiasis mansoni: effect of transfer factor on early established infections. (1975) (3)
SALMONELLA ARTHRITIS (1925) (2)
Cellular Hypersensitivity and Immunity (Part 2 of 3) (1972) (2)
Lysosomes in immunity to schistosomes and other helminths. (1979) (2)
Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes. (1972) (2)
The role of eosinophils in immunity to parasites: an introduction. (1977) (2)
Cellular hypersensitivity: the production of antibody by cultures of lymphocytes producing macrophage inhibitory factor. (1972) (2)
Leishmania major Cutaneous Gene Develop Th 1 Response and Control Genetically Resistant Mice Lacking IL-18 (2000) (2)
Helminthotoxic capacity of eosinophils vs. neutrophils. (1981) (2)
SALMONELLA arthritis. (1953) (2)
Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF). (1988) (1)
Host-parasite interface: immune evasion. (1990) (1)
Soluble Mediators of Delayed Hypersensitivity (1971) (1)
Lymphocyte Mediators, Activated Macrophages, and Tumor Immunity (1976) (1)
Expression of Glycolipid Receptor for Human Migration Inhibitory Factor as a Function of Tumor Cell Differentiation a (1984) (1)
A CONTROLLED STUDY OF TRANSFER FACTOR IN PROTEIN-CALORIE MALNUTRITION (1975) (1)
BIOCHEMICAL CHARACTERIZATION OF LYMPHOCYTE MEDIATOR-MACROPHAGE INTERACTIONS* (1980) (1)
Further studies on murine migration inhibitory factor (MIF) (1976) (1)
Interactions between immunocompetent cells and target cells or antigens. (1967) (1)
The ability of mouse monoclonal antibodies to direct the cytotoxic function of cytokine-activated human eosinophils. (1990) (1)
Delayed Hypersensitivity in Vitro (1964) (1)
InVivoandInVitro Characterization ofMurineT-Cell Clones Reactive toMycobacterium tuberculosis (1987) (1)
SEPARATION OF HUMAN MONOCYTES AND GUINEA PIG MACROPHAGES BY DENSITY GRADIENTS OF METRIZAMIDE (1981) (1)
Fractionated total lymphoid irradiation can induce temporary relief in refractory rheumatoid arthritis. (1981) (1)
MEDIATOR PRODUCTION BY HUMAN T AND B LYMPHOCYTES (2003) (1)
[Activation of macrophages by lymphocyte mediators (author's transl)]. (1980) (1)
Infection L. major Against It Protects Against and Vaccinating Leishmania major with Sandfly Maxadilan Exacerbates Infection (2001) (1)
Transfer Factor and Cellular Immune Deficiency (1972) (1)
Satire : a critical anthology (1967) (1)
Recombinant human migration inhibitory factor has adjuvant activity. (1993) (1)
Recombinant Migration Inhibitory Factor (MIF): its Potential as an Adjuvant for Developing Vaccines (1993) (1)
Correction to A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia [The Journal of Experimental Medicine 203, 5, (2006), 1185-1196] (2015) (0)
Generation and characterization of human t cell hybridoma migration inhibitory factor and of murine monoclonal anti human migration inhibitory factor antibodies (1984) (0)
by Products of Sensitized Lymphocytes (1974) (0)
Enhancement of macrophage activating factor (MAF) activity by preincubating macrophages (Mφ) with diazotized sulfanilic acid (DSA) or antithrombin III (AT-III)☆☆☆ (1976) (0)
Antigen-Specific IgG 2 a Antibody Response Response but Fail to Mount an Efficient NK Cell-Deficient Mice Develop a Th 1-Like (1999) (0)
METABOLIC A ND F UNCTIONAL S TUDIES O N A CTIVATED MOUSE M ACROPHAGES (1973) (0)
Cellular immunity: alterations of macrophage functions by mediators from lymphocytes. (1972) (0)
Production and characterization of mouse migration inhibitory factor (mif). Abstr. (1975) (0)
Guinea Pig Lymphotoxin (LT) (1973) (0)
Infection Leishmania major Th1 Response and Control Cutaneous Mice Lacking NK Cells Develop an Efficient (1999) (0)
JUVENILE RHEUMATOID ARTHRITIS CELLULAR HYPERSENSITIVITY AND SELECTIVEIgADEFICIENCY (1972) (0)
Cellular Hypersensitivity and Immunity (Part 3 of 3) (1972) (0)
SignalingMediated by Th2 Response Induced Via STAT6 Is Taenia crassiceps of the Helminth Parasite Cutting Edge: Susceptibility to the Larval Stage (2002) (0)
CHARACTERIZATION OF A LYMPHOCYTE FACTOR W H I C H ALTERS MACROPHAGE FUNCTIONS* BY CARL F. NATHAN, HEINZ G. REMOLD,~ AND JOHN R. DAVID (2003) (0)
The Biology of Parasitism (Course At Woods Hole, Part II) The Future of Immunology (As It Pertains To Parasitology, Part I) (1983) (0)
Letter: A controlled study of transfer factor in protein-calorie malnutrition. (1975) (0)
Membrane fusion between polymorphonuclear leukocytes and schistosoma mansoni (1979) (0)
(complement system/serine proteases/sialidase/parasites/protozoa) (2016) (0)
Antigen-dependent heterogeneity of human migration inhibitory factor. (1985) (0)
Book ReviewCellular Recognition. (1970) (0)
Current Concepts of Delayed Hypersensitivity (1967) (0)
CHARACTERIZATION OF THREE HUMAN MIGRATION INHIBITORY FACTORS (MIF) AND THEIR SPECIFIC PRODUCTION BY DIFFERENT ANTIGENS1 (1983) (0)
Immunology and molecular biology of tropical infectious diseases (1993) (0)
Pernicious anemia, concordant twins, and immune dysfunction (1971) (0)
BIOCHEMICAL CHARACTERIZATION OF MIF/MAF-MACROPHAGE INTERACTIONS: A putative glycolipid receptor for MIF, the existence of two distinct MIFs, and their regulation by macrophage-associated esterases (1979) (0)
Functional studies onpurified eosinophils andneutrophils from patients withSchistosoma mansoni infections (1980) (0)
Migration Inhibitory Factor Impairs Murine Cutting Edge: Deficiency of Macrophage (2006) (0)
Plasminogen Activator Production by Human Monocytes (1979) (0)
Cell-associated Hypersensitivity Studied in Vitro1 (2006) (0)
Quantitative correspondence betw( activity of teratogenic agents (2016) (0)
Round Table Conference on Allergen Standardization (1971) (0)
From monomers to polymers through catalysis (1997) (0)
Polypeptide (PACAP) Receptor the Pituitary Adenylate Cyclase-Activating Mouse Macrophages Through Interaction with and Induces IL-6 by a Saliva Inhibits TNF-The Vasoactive Peptide Maxadilan from Sand Fly (1998) (0)
ENHANCEMENT OF PINOCYTOSIS IN THE MACROPHAGE BY MACROPHAGE ACTIVATING FACTOR (1977) (0)
Role of Macrophage Migration Inhibitory Factor (MIF) in Parasitic Diseases (2012) (0)
Murine MIF does not contain Ia determinants. (1979) (0)

This paper list is powered by the following services:

Other Resources About John David

en.wikipedia.org

What Schools Are Affiliated With John David ?

John David is affiliated with the following schools:

John David 's Academic­Influence.com Rankings